|Articles|April 25, 2022

Tufts CSDD Patient Engagement Survey

New survey will assess how pharma and biotech companies are incorporating patient engagement into their drug development organizations and operations.

The survey is very brief—it should take only 20-25 minutes to complete. All responses are confidential and will only be reported in the aggregate.

The survey can be found here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Tufts CSDD Patient Engagement Survey

Related Content

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

What a Lean Development Model Actually Means for Biotech Operations Today

ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap

Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters

Why Commercialization Readiness Can No Longer Wait Until End of Phase II

Trending on Applied Clinical Trials Online

ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap

ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial

Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

ACT Brief: NIH Funding Reshaping Development Strategy, Business Decision Setting Execution Course, and Complex Modality Platform Gaps